acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 21 Feb 2023 Acarix receives breakthrough order from US Veterans Health Administration Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the first order from the US Veterans Health Administrati... Continue reading
acarix Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish November 18, 2024 21 Feb 2023 Acarix erhåller genombrottsorder från US Veterans Health Administration Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, bekräftar idag att bolaget erhållit den första order... Continue reading
acarix Interim, IR, Listing Regulation, News, Regulatory, Report, Swedish, Yearend November 18, 2024 16 Feb 2023 Acarix AB (publ) publicerar Bokslutskommuniké 2022 Strategiskt skifte till fullt kommersiellt fokus på USA-marknaden nu på platsNär vi summerar 2022 blir det tydligt att... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend November 18, 2024 16 Feb 2023 Acarix AB (publ) publishes Year-End Report 2022 Strategic shift towards full commercial focus on the US market now in placeAs we sum up 2022, it becomes clear that Acarix has in a sho... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 14 Feb 2023 ACARIX strengthens US Commercial Team Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of two additional members of the Acarix ... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 14 Feb 2023 ACARIX förstärker USA:s kommersiella team Acarix, en ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag anställningen av två nya medlemmar till A... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 13 Feb 2023 Invitation to presentation of Acarix´s fourth quarter report Acarix will publish its fourth quarter results on Thursday 16 February 2023 at 08.00 am (CEST). A live webcast will be held at 11.00 (C... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 13 Feb 2023 Inbjudan till presentation av Acarix delårsrapport för fjärde kvartalet Acarix publicerar sin rapport för fjärde kvartalet torsdagen den 16 februari 2023 kl 08.00. En direktsänd websändni... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 07 Feb 2023 Acarix is attending 2023 BIO CEO & Investor Conference in New York City Acarix, a leader in innovative acoustic and AI-based cardiac diagnostics, will be attending for the first time the 25th annual BIO CEO ... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 07 Feb 2023 Acarix deltar i 2023 BIO CEO & Investor Conference i New York City Acarix, en ledare inom akustisk och AI-baserad hjärtdiagnostik, kommer för första gången att delta i den 25:e &ari... Continue reading
acarix Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares November 18, 2024 23 Jan 2023 Acarix announces last day of trading with BTU and first day of trading in warrants THIS ANNOUNCEMENT IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, C... Continue reading
acarix Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish November 18, 2024 23 Jan 2023 Acarix meddelar sista dag för handel med BTU och första dag för handel med teckningsoptioner DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELL... Continue reading